By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oncolinx 

745 Atlantic Avenue

Boston  Massachusetts  02111  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Oncolinx is developing the next generation of antibody-drug conjugates (ADCs)--powerful, targeted cancer therapies that are more effective and have dramatically fewer side effects than current methods of cancer treatment. These therapies can be targeted to nearly any type of cancer and are rapidly becoming the state-of-the-art in cancer treatment. Drawing on the scientific innovation of the National Cancer Institute, the world's leading biotechs and life sciences companies, Oncolinx is redefining the paradigm of cancer therapy.

YEAR FOUNDED:

May 2013

LEADERSHIP:

Co-Founder and CEO: Sourav Sinha

Co-Founder and COO: Riley Ennis

Co-Founder and CSO: Allen Lin

Business Development Advisor: John Tagliamonte

Lead Inventor, Scientific Advisory Board: Nadya Tarasova, PhD


Key Statistics


Email: contact@oncolinx.com
Ownership: Private

Web Site: Oncolinx
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->